Panagora Asset Management Inc Astrazeneca PLC Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $1.36 Million - $1.52 Million	-21,980 Reduced 73.25%	8,028 $540,000
Q3 2023 Oct 31, 2023	BUY	$64.85 - $71.7 $125,030 - $138,237	1,928 Added 6.87%	30,008 $2.03 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $1.15 Million - $1.25 Million	16,450 Added 141.44%	28,080 $2.01 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $734,434 - $832,707	11,630 New	11,630 $807,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $71,289 - $85,581	-1,203 Reduced 10.06%	10,753 $710,000
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $236,754 - $285,192	4,249 Added 55.13%	11,956 $793,000
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $1.45 Million - $1.71 Million	-26,795 Reduced 77.66%	7,707 $449,000
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $68,616 - $75,075	1,235 Added 3.71%	34,502 $2.07 Million
Q2 2021 Aug 11, 2021	SELL	$48.42 - $60.18 $259,676 - $322,745	-5,363 Reduced 13.88%	33,267 $1.99 Million
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $1.75 Million - $2.03 Million	-37,209 Reduced 49.06%	38,630 $1.92 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $1.25 Million - $1.5 Million	-25,776 Reduced 25.37%	75,839 $3.79 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $44,897 - $51,690	-846 Reduced 0.83%	101,615 $5.57 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $1.7 Million - $2.18 Million	39,371 Added 62.4%	102,461 $5.42 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $1.31 Million - $1.79 Million	34,795 Added 122.97%	63,090 $2.82 Million
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $138,929 - $165,105	-3,272 Reduced 10.37%	28,295 $1.41 Million
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $484,890 - $549,550	12,086 Added 62.04%	31,567 $1.41 Million
Q2 2019 Aug 09, 2019	BUY	$37.28 - $41.68 $69,415 - $77,608	1,862 Added 10.57%	19,481 $804,000
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $8,375 - $10,152	-236 Reduced 1.32%	17,619 $712,000
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $149,430 - $168,200	4,054 Added 29.37%	17,855 $678,000
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $479,722 - $548,175	13,801 New	13,801 $546,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.11 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.74 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.43 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.41 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.25 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account